YL Biologics (YLB), a joint venture by drugmaker Lupin and Yoshindo, has successfully completed the late phase clinical ...
Scottish firm TC BioPharm has inked a strategic collaboration with the Japan’s NIPRO Corporation to co-d...
The Japan Prize Foundation has announced Max D. Cooper, MD, as a laureate of the 2018 Japan Prize. Cooper will receive a...
Researchers at Florey Institute of Neuroscience and Mental Health, and University of Melbourne, Australia and Japanese N...
A team of researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, has report...
BiomX Ltd., a microbiome company, announced that it has exclusively sub-licensed a set of bacterial targets from JSR Cor...
A team of experts at the University of Tokyo's Institute of Industrial Science (IIS) has developed a new probe that coul...
Hitachi, Ltd. and Hokkaido University announced that it has obtained U.S. Food & Drug Administration (FDA) 510(k) cl...
Tokyo based Astellas Pharma Inc. recently announced the acquisition of Mitobridge, Inc. Astellas paid $225 million to ac...
Sato Pharmaceutical Co., Ltd. has obtained marketing and manufacturing approval for the oral antifungal agent, Nailin ca...
Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic...
Storm Therapeutics, a Cambridge Life Sciences firm has attracted an additional £4m cash injection to its £12...
Takeda Pharmaceutical is planning to acquire Belgian biopharmaceutical venture TiGenix with an aim of strengthening...
Alexion Pharmaceuticals, recently bagged approval for its key candidate Soliris (eculizumab) fromthe Ministry of Health,...
A group of researchers at Osaka University, Japan have refined the method of making bio-ink droplets stick to each other...
US based X-Chem, Inc. and Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. headquartered in To...
Scientists at Tohoku University in Japan have created a database of metabolites from blood samples collected from over 5...
Israel based Yozma Group is planning to invest in Japanese startups in the coming year, targeting companies in medicine,...
